BRCA2 linked to inferior outcomes with CDK4/6 inhibitors plus endocrine therapy Presented ByDr Anton Safonov, Memorial Sloan-Kettering Cancer Center, NY, USA ConferenceSABCS 2021 TypePeer-reviewed article 31 January 2022 18:08